Brief: IX Biopharma Says Exploring Possibility Of A Spin-Off Of Its Pharmaceutical Business
12/07/2021 02:11
July 12 (Reuters) - IX Biopharma Ltd IXBI.SI :
* EXPLORING POSSIBILITY OF A SPIN-OFF OF ITS PHARMACEUTICAL
BUSINESS
* INTENDS TO RESTRUCTURE ITS PHARMACEUTICAL BUSINESS TO BE
HELD BY
LIGO PHARMA
* POSSIBLE SPIN OFF BY WAY OF LISTING ON MAIN BOARD OF HKEX
* POST RESTRUCTURING, SPIN-OFF CO WILL BE ENGAGED IN
MANUFACTURING, RESEARCH AND DEVELOPMENT, & SALES OF
PHARMACEUTICAL & MEDICINAL CANNABIS PRODUCTS
Source text for Eikon: ID:nSN9Vn41q
Further company coverage: IXBI.SI
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IX Biopharma
See all newsBrief: IX Biopharma Says Co Will Undertake An Internal Restructuring Of Its Consumer Business
Brief: IX Biopharma To Issue 1 MLN New Shares To Anson Properties At S$0.4215 Per Share
Brief: IX Biopharma Says US Government Awards US$41 MLN Contract To Fund Development Of Wafermine
Brief: IX Biopharma To Raise At Least S$6 MLN Via Placement At S$0.198 Per Share
Brief: IX Biopharma Enters Term Sheet For Proposed Joint Venture